Profile
Kirsten Gruis served as Chief Medical Officer at DiaMedica Therapeutics, PTC Therapeutics GT, and Edgewise Therapeutics.
She received her undergraduate and doctorate degrees from the University of Iowa and her graduate degree from the University of Michigan School of Public Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-24 | 0 ( -.--% ) | - $ | 2024-05-30 |
Former positions of Kirsten Gruis
| Companies | Position | End |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2023-08-30 |
PTC Therapeutics GT, Inc.
 PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk. | Chief Tech/Sci/R&D Officer | - |
| EDGEWISE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Kirsten Gruis
| University of Iowa | Doctorate Degree |
| University of Michigan School of Public Health | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| DIAMEDICA THERAPEUTICS INC. | Health Technology |
| EDGEWISE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
PTC Therapeutics GT, Inc.
PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk. | Health Technology |
- Stock Market
- Insiders
- Kirsten Gruis
